The 51th Union World Conference On Lung Health

October 20, 2020 - 1:45pm - October 24, 2020 - 1:45am

MSH is pleased to participate in the 51st Union World Conference on Lung Health, October 20-24, 2020 under the theme ‘Advancing Prevention. 


Committed to ending TB by 2030, the global community has set ambitious targets for countries to achieve by 2022: successfully treat 40 million people with TB and provide TB preventive therapy for at least 30 million people.

With a presence in 19 of USAID’s 23 TB high-priority countries, MSH is ready to accelerate and expand our locally led efforts to eliminate TB.

Learn more about MSH’s new TB projects

Our approach strengthens health systems for TB prevention and control—building skills and sustainability, strengthening laboratory systems, ensuring continuous availability of medicines and supplies, integrating TB into HIV and other health services, and bolstering health financing and local governance.

We invite you to join two conference sessions, co-chaired by MSH. 

Symposium: Leveraging a multiplex platform for TB, HIV and coronavirus testing, country experiences

Thursday, October 22, 4:30 PM CEST, co-chaired by Alaine Nyaruhirira, Senior Laboratory Technical Advisor, MSH

The global roll out of two WHO-recommended rapid tests, Xpert MTB/RIF and Ultra, have accelerated progress towards universal access to TB diagnosis. The GeneXpert platform, used for these tests, can also detect multiple diseases including HIV, hepatitis, Ebola, and now COVID-19. 

With the onset of the COVID-19 pandemic, how have countries engaged in planning and investment to ensure efficiencies and integration and avoid disruptions in TB diagnosis and services? 

Speakers from Nigeria, Kyrgyz Republic, Indonesia, and Rwanda will share lessons learned about TB management during the COVID-19 outbreak. 

Find more details here

A workshop on improved diagnostic technologies: Xpert MTB/RIF Ultra sensitivity implementation and clinical management

Thursday, October 29, 1-5 PM CEST, chaired by Alaine Nyaruhirira, Senior Laboratory Technical Advisor, MSH

The World Health Organization recommends the use of Xpert MTB/RIF Ultra tests (Ultra for short) for faster and more accurate diagnosis among people with signs or symptoms of TB. 

As many National TB Programs use Ultra tests, this workshop will focus on the effect these tests have on strategies and approaches for the treatment and management of TB, especially for drug-resistant TB and co-infected HIV/TB patients.

Speakers from Malawi, South Africa, Uganda, Belarus, and Pakistan will share their experiences with this diagnostic technology. 

Register here



Our volume of peer-reviewed journal articles highlights MSH’s long-term commitment to ending the TB epidemic. Authored and co-authored by MSH technical experts, these articles are important contributions to the evidence base of what works in the fight against TB, including systems strengthening innovations that improve access to both established and novel TB medicines, ensuring safety and quality, and promoting effective detection and case management.

Newly published: 

Factors Determining Treatment Success in Children with Drug-Sensitive Tuberculosis in Ethiopia: A Three-Year Retrospective Analysis, September 21, 2020

Active household contact screening for tuberculosis and provision of isoniazid preventive therapy to under-five children in Afghanistan, October 9, 2020



MSH has developed materials highlighting our technical approaches, results, and lessons from across our TB projects with multiple partners. These technical documents have been collected in this compendium to share our experiences and insights with other partners and implementers to continue the fight toward ending the TB epidemic.